Literature DB >> 16260726

Detection of functional single-nucleotide polymorphisms that affect apoptosis.

Sandra L Harris1, German Gil, Harlan Robins, Wenwei Hu, Kim Hirshfield, Elisabeth Bond, Gareth Bond, Arnold J Levine.   

Abstract

Human EBV-transformed B lymphocyte cell lines (LCLs) were used to measure the apoptotic response of individuals to gamma radiation. The responses form a normal distribution around a median of 35.5% apoptosis with a range of 12-58%. This heterogeneous response has a genetic basis. LCLs from Caucasian donors and African American donors form distinct distributions of apoptotic response; all of the 11 LCLs comprising the lowest responding group (exhibiting between 12-20% apoptosis) are from Caucasian donors. The assay is capable of detecting significant effects of SNPs in two genes, MDM2 and AKT1, whose products are involved in controlling the p53 pathway and cellular response to DNA damage, suggesting that these data and this assay can be used to identify novel SNPs in other genes whose products impact the cellular response to radiation. Finally, the LCLs in the lowest apoptotic response group have the highest concentration of AKT1 protein and all harbor a haplotype in AKT1 that is present in Caucasians but absent in African Americans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260726      PMCID: PMC1283473          DOI: 10.1073/pnas.0508390102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  A novel site of AKT-mediated phosphorylation in the human MDM2 onco-protein.

Authors:  Diane Milne; Petros Kampanis; Samantha Nicol; Sylvia Dias; David G Campbell; Frances Fuller-Pace; David Meek
Journal:  FEBS Lett       Date:  2004-11-05       Impact factor: 4.124

Review 2.  The p53 pathway: positive and negative feedback loops.

Authors:  Sandra L Harris; Arnold J Levine
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

Review 3.  MDM2 is a central node in the p53 pathway: 12 years and counting.

Authors:  Gareth L Bond; Wenwei Hu; Arnold J Levine
Journal:  Curr Cancer Drug Targets       Date:  2005-02       Impact factor: 3.428

4.  p53 is required for radiation-induced apoptosis in mouse thymocytes.

Authors:  S W Lowe; E M Schmitt; S W Smith; B A Osborne; T Jacks
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

5.  A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

Authors:  Gareth L Bond; Wenwei Hu; Elisabeth E Bond; Harlan Robins; Stuart G Lutzker; Nicoleta C Arva; Jill Bargonetti; Frank Bartel; Helge Taubert; Peter Wuerl; Kenan Onel; Linwah Yip; Shih-Jen Hwang; Louise C Strong; Guillermina Lozano; Arnold J Levine
Journal:  Cell       Date:  2004-11-24       Impact factor: 41.582

6.  Effects of genetic background on tumorigenesis in p53-deficient mice.

Authors:  L A Donehower; M Harvey; H Vogel; M J McArthur; C A Montgomery; S H Park; T Thompson; R J Ford; A Bradley
Journal:  Mol Carcinog       Date:  1995-09       Impact factor: 4.784

7.  Follow-up study of twenty-four families with Li-Fraumeni syndrome.

Authors:  J E Garber; A M Goldstein; A F Kantor; M G Dreyfus; J F Fraumeni; F P Li
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

8.  Genetic analysis of genome-wide variation in human gene expression.

Authors:  Michael Morley; Cliona M Molony; Teresa M Weber; James L Devlin; Kathryn G Ewens; Richard S Spielman; Vivian G Cheung
Journal:  Nature       Date:  2004-07-21       Impact factor: 49.962

9.  p53-dependent apoptosis suppresses tumor growth and progression in vivo.

Authors:  H Symonds; L Krall; L Remington; M Saenz-Robles; S Lowe; T Jacks; T Van Dyke
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

10.  Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation.

Authors:  Jianhua Feng; Rastislav Tamaskovic; Zhongzhou Yang; Derek P Brazil; Adrian Merlo; Daniel Hess; Brian A Hemmings
Journal:  J Biol Chem       Date:  2004-05-28       Impact factor: 5.157

View more
  31 in total

1.  DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.

Authors:  Giuseppe Blasi; Francesco Napolitano; Gianluca Ursini; Paolo Taurisano; Raffaella Romano; Grazia Caforio; Leonardo Fazio; Barbara Gelao; Annabella Di Giorgio; Luisa Iacovelli; Lorenzo Sinibaldi; Teresa Popolizio; Alessandro Usiello; Alessandro Bertolino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion.

Authors:  Hyunjoo Lee; Shabirul Haque; Jennifer Nieto; Joshua Trott; John K Inman; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2012-05-18       Impact factor: 5.422

3.  Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.

Authors:  Qiang Fu; Guoqiang Zhang; Hongwei Chen; Youwei Zheng; Jing Cheng
Journal:  Tumour Biol       Date:  2013-08-03

Review 4.  MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.

Authors:  Yan Li; Hongjin Zhao; Li Sun; Linjuan Huang; Qifeng Yang; Beihua Kong
Journal:  Hum Cell       Date:  2011-03-04       Impact factor: 4.174

5.  The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer.

Authors:  Lindsay M Almquist; Margaret R Karagas; Brock C Christensen; Marleen M Welsh; Ann E Perry; Craig A Storm; Heather H Nelson
Journal:  Carcinogenesis       Date:  2010-12-01       Impact factor: 4.944

6.  AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families.

Authors:  Dawn L Thiselton; Vladimir I Vladimirov; Po-Hsiu Kuo; Joseph McClay; Brandon Wormley; Ayman Fanous; Francis A O'Neill; Dermot Walsh; Edwin J C G Van den Oord; Kenneth S Kendler; Brien P Riley
Journal:  Biol Psychiatry       Date:  2007-09-06       Impact factor: 13.382

7.  Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population.

Authors:  Q Xu; X Wu; M Li; H Huang; C Minica; Z Yi; G Wang; L Shen; Q Xing; Y Shi; L He; S Qin
Journal:  Pharmacogenomics J       Date:  2015-08-18       Impact factor: 3.550

8.  Epistatic and functional interactions of catechol-o-methyltransferase (COMT) and AKT1 on neuregulin1-ErbB signaling in cell models.

Authors:  Yoshitatsu Sei; Zhen Li; Jian Song; Renee Ren-Patterson; Elizabeth M Tunbridge; Yukihiko Iizuka; Masahiro Inoue; Berenice T Alfonso; Senda Beltaifa; Yoko Nakai; Bhaskar S Kolachana; Jingshan Chen; Daniel R Weinberger
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

9.  Stress-specific response of the p53-Mdm2 feedback loop.

Authors:  Alexander Hunziker; Mogens H Jensen; Sandeep Krishna
Journal:  BMC Syst Biol       Date:  2010-07-12

10.  Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans.

Authors:  Hao-Yang Tan; Kristin K Nicodemus; Qiang Chen; Zhen Li; Jennifer K Brooke; Robyn Honea; Bhaskar S Kolachana; Richard E Straub; Andreas Meyer-Lindenberg; Yoshitasu Sei; Venkata S Mattay; Joseph H Callicott; Daniel R Weinberger
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.